Co-Diagnostics, Inc. (CODX)
NASDAQ: CODX · IEX Real-Time Price · USD
1.110
-0.030 (-2.63%)
Apr 26, 2024, 4:30 PM EDT - Market closed

Co-Diagnostics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current202320222021202020192018201720162015
Market Capitalization
354178258263161932--
Market Cap Growth
--47.80%-69.80%-1.85%1593.67%-19.33%-40.66%---
Enterprise Value
-21-15-316821615202921
PE Ratio
-1.15-1.15-5.477.046.19-2.50-3.07-4.66--
PS Ratio
5.095.972.282.643.5372.21482.134232.19--
PB Ratio
0.400.470.681.923.948.94-18.178.42--
P/FCF Ratio
-1.73-1.7315.156.399.60-2.75-4.67-9.71--
P/OCF Ratio
-1.84-1.8411.866.289.33-2.81-4.72-10.10--
EV/Sales Ratio
-2.19-2.19-0.091.722.8968.05506.153770.90-97.77
EV/EBITDA Ratio
0.400.400.183.665.05-2.43-3.32-4.38-1.45-0.51
EV/EBIT Ratio
0.390.390.163.685.06-2.40-3.29-4.35-1.42-0.50
EV/FCF Ratio
0.630.63-0.604.167.87-2.59-4.90-8.65-1.81-0.59
Debt / Equity Ratio
0.030.030.00----1.80--1.13-0.88
Debt / EBITDA Ratio
-0.08-0.08-0.02----0.31--2.06-0.53
Debt / FCF Ratio
-0.13-0.130.07----0.46--2.56-0.61
Quick Ratio
10.2410.2421.898.7914.633.120.415.630.260.04
Current Ratio
10.8110.8123.949.1416.694.830.457.090.310.15
Asset Turnover
0.060.060.230.891.610.050.020.000-
Interest Coverage
------57.21-45.48-21.43-7.01-26.17
Return on Equity (ROE)
-35.40%-35.40%-10.50%36.80%97.40%-160.50%-872.00%-1626.10%93.10%-
Return on Assets (ROA)
-32.60%-32.60%-9.40%33.40%91.80%-141.90%-262.30%-233.60%-231.40%-
Return on Capital (ROIC)
-47.98%-47.98%-23.49%27.52%62.38%-339.26%-719.95%-118.53%-422.53%1448.65%
Earnings Yield
-101.83%-86.87%-18.27%14.21%16.16%-39.91%-32.59%-21.46%--
FCF Yield
-67.57%-57.65%6.60%15.66%10.42%-36.32%-21.42%-10.30%--
Buyback Yield / Dilution
6.77%6.77%-5.27%-6.80%-67.10%-34.22%-13.91%-10.91%-5.54%-
Total Shareholder Return
6.77%6.77%-5.27%-6.80%-67.10%-34.22%-13.91%-10.91%-5.54%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).